Skip to main content
Clinical Trials/CTRI/2019/02/017436
CTRI/2019/02/017436
Completed
未知

A Feasibility Study to Evaluate the Safety and Performance of theEndoSleeveâ?¢ System in Over-weight or Obese patients withType 2 Diabetes Mellitus

Metamodix Inc0 sites15 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E669- Obesity, unspecifiedHealth Condition 2: E116- Type 2 diabetes mellitus with other specified complications
Sponsor
Metamodix Inc
Enrollment
15
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
April 3, 2018
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Metamodix Inc

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \> 18 years and \< 65 years â?? Male or Female
  • 2\. BMI \> 25 kg/m2 and \< 40 kg/m2
  • 3\. Patient with Type 2 Diabetes and being treated by diet or
  • oral anti\-diabetes agents (Metformin, DPP\-4i, SU or TZD)
  • 4\. HbA1c at screening \> 7\.0 and \< 10\.0%
  • 5\. Patient or legal representative of the patient is willing and
  • able to sign an IEC approved informed consent form and
  • agrees to comply with study requirements

Exclusion Criteria

  • 1\. Patients requiring injectable treatments (insulin, GLP\-1R
  • 2\. Patients with Type 1 Diabetes Mellitus or having any history of
  • ketoacidosis
  • 3\. Patients with iron deficiency and iron deficiency anemia
  • 4\. Patients requiring anticoagulation therapy
  • 5\. Patients with inflammatory bowel disease or condition of the
  • gastrointestinal tract, such as ulcers or Crohnâ??s disease
  • 6\. Patients with pancreatitis or other serious organic conditions
  • 7\. Patients with known gallstones prior to implant
  • 8\. Patients with known infection at the time of implant

Outcomes

Primary Outcomes

Not specified

Similar Trials